drugset / Trial / NCT00437164
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
Many drugs used for the treatment of Type 2 Diabetes Mellitus cause the body to retain water. This study will assess whether or not GW677954 causes the body to retain fluid.
Timeline
- Start
- 2006-09
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SODELGLITAZAR | Small molecule | 15 mg | Oral |
| Background | Insulin | Protein / enzyme biologic | — | — |